NEUROBLASTOMA
DEFINITION:
A tumour of post-ganglionic sympathetic neurons characterized by
an abdominal mass and varied clinical manifestations.
EPIDEMIOLOGY:
- prevalence: 1/10,000 live births
- most common extracranial solid tumor in children
- makes up 8-10% of all childhood cancer
- age of onset:
- median age - 2 years
- 75% diagnosed by - 5 years
- 97% diagnosed by - 10 years
- risk factors:
- familial - chrom.#: 1p36.2-p36.1
- whites > blacks
- males > females (1.2:1)
PATHOGENESIS:
CLINICAL FEATURES:
1. Primary Tumors
1. Adrenal Medulla
- abdominal mass and/or pain - firm, irregular, non-tender
- anorexia, vomiting
2. Extra-Adrenal
- cervical ganglia - Horner syndrome, heterochromia
- thoracic - dysphagia, dyspnea, infections, chronic cough
- pelvic - difficulty with defecation or urination
- paraspinal - back pain, paraplegia, stool/urine retention
2. Metastases
1. Bone Marrow - pain, pancytopenia
2. Cortical Bone - pain (long bone); periorbital ecchymosis,
proptosis (skull)
3. Liver - hepatomegaly, distension
4. Lung - dyspnea, infections
5. Lymph Nodes - left supraclavicular, cervical, inguinal
6. Skin - multiple subcutaneous bluish nodules
3. Paraneoplastic Syndromes
1. Angiotensin - hypertension (stretching of renal artery)
2. Catecholamines - flushing, hypertension
3. VIP Syndrome - watery diarrhea, distension
4. Opsoclonus-Myoclonus Syndrome - myoclonic jerks; chaotic
conjugate eye movements
5.Progressive Cerebellar Ataxia
INVESTIGATIONS:
1. Imaging Studies
- Chest X-Ray, Abdominal X-Ray, skeletal survey, Abdominal
ultrasound
- CT - chest, abdomen
- Body Scan - 131I-MIBG (taken up by neuroblasts)
- Bone Scan - Tc-99 MDP
2. Pathology
1. Tumor
- undifferentiated small, round, blue-cell tumor (also seen
with Rhabdomyosarcoma and Ewings Sacroma)
- karyotype, DNA index, N-myc copy number
2. Bone Marrow
- neuroblastoma, pancytopenia
3. Biologic
1. Urine
- elevated homovanillic acid (HVA) and vanillymandelic acid
(VMA) - 90-95% of tumors secrete catecholamines - elevated
metanephrine and normetanephrine
2. Serum
- elevated levels of:
- enolase (neuron-specific)
- ferritin
- LDH (represents tumor load)
STAGING:
- International Neuroblastoma Staging System (1988)
- Stages 1 - 4S
POOR PROGNOSTIC INDICATORS:
1. Clinical/Biologic
- Stage IV
- Stage III with
- increased enolase (>100 ug/L)
- increased ferritin (>142 ug/L)
- increased LDH (>1500 IU/L)
- increased N-myc copies
- age >1 year
- adrenal tumor
- undifferentiated cells (with diploid DNA)
- multiple N-myc copies
- chronic 1p deletion
MANAGEMENT:
1. Surgery
- primary and "second-look" operations
2. Chemotherapy
- mainstay of therapy
- pairs and combinations of drugs used
- has not had a significant impact in older patients
- CCSG Protocol
- cisplatinum
- etoposide
- adriamycin
- cyclophosphamide
|